Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
Wed, 18.09.2024
Nordex SE
• 10 Turbines on hybrid towers developed in-house by Nordex with a hub height of 179 metres
• Nordex breaks the 70 GW order intake mark since its foundation
Hamburg, 18 September 2024. The wind and solar park developer UKA (Umweltgerechte Kraftanlagen GmbH & Co. KG) has ordered 10 turbines from the Nordex Group from the latest Delta4000 s [ … ]
Wed, 18.09.2024
DEMIRE Deutsche Mittelstand Real Estate AG
DEMIRE lets around 1,900 m² to FrontWell in Bad Vilbel
Langen, 18 September 2024. DEMIRE Deutsche Mittelstand Real Estate AG (ISIN: DE000A0XFSF0) has let around 1,900 m² of space in Bad Vilbel to FrontWell Solutions. The lease was concluded for five years. FrontWell Solutions is a globally operating consulting firm providing manufacturing digitali [ … ]
Wed, 18.09.2024
DEMIRE Deutsche Mittelstand Real Estate AG
DEMIRE lets around 1,900 m² to FrontWell in Bad Vilbel
Langen, 18 September 2024. DEMIRE Deutsche Mittelstand Real Estate AG (ISIN: DE000A0XFSF0) has let around 1,900 m² of space in Bad Vilbel to FrontWell Solutions. The lease was concluded for five years. FrontWell Solutions is a globally operating consulting firm providing manufacturing digitali [ … ]
Wed, 18.09.2024
Relief Therapeutics Holding SA
Relief Therapeutics Holding SA
/ Key word(s): Study
Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024
18.09.2024 / 07:00 CET/CEST
Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October [ … ]
Wed, 18.09.2024
Relief Therapeutics Holding SA
Relief Therapeutics Holding SA
/ Key word(s): Study
Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024
18.09.2024 / 07:00 CET/CEST
Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October [ … ]
Tue, 17.09.2024
Leclanché SA
Leclanché SA
/ Key word(s): Conference
Leclanché to Exhibit at InnoTrans 2024 in Berlin, Showcasing Advanced Rail Traction Battery Systems
17.09.2024 / 22:00 CET/CEST
Leclanché to Exhibit at InnoTrans 2024 in Berlin, Showcasing Advanced Rail Traction Battery Systems
Leclanché to display both generic INT-53 Energy and t [ … ]
Tue, 17.09.2024
Leclanché SA
Leclanché SA
/ Key word(s): Conference
Leclanché to Exhibit at InnoTrans 2024 in Berlin, Showcasing Advanced Rail Traction Battery Systems
17.09.2024 / 22:00 CET/CEST
Leclanché to Exhibit at InnoTrans 2024 in Berlin, Showcasing Advanced Rail Traction Battery Systems
Leclanché to display both generic INT-53 Energy and t [ … ]
Tue, 17.09.2024
Netfonds AG
PRESS RELEASE
Strong result and first-time publication of a balance sheet for the first half of 2024
● Final result underlines successful first half of 2024
● Assets at new record level
● Growth in the wealth management segment
● Further acquisitions increase future earning powerHamburg, 17 September 2024 - Netfonds AG (ISIN: DE000A1MME [ … ]
Tue, 17.09.2024
Netfonds AG
PRESS RELEASE
Strong result and first-time publication of a balance sheet for the first half of 2024
● Final result underlines successful first half of 2024
● Assets at new record level
● Growth in the wealth management segment
● Further acquisitions increase future earning powerHamburg, 17 September 2024 - Netfonds AG (ISIN: DE000A1MME [ … ]
Tue, 17.09.2024
DFV Deutsche Familienversicherung AG
Withdrawal of shares from trading at the Frankfurt Stock Exchange – Haron Holding S.A. makes voluntary public takeover and delisting offer
Frankfurt/Main, 17. September 2024 – Today, DFV Deutsche Familienversicherung AG and Haron Holding S.A. have concluded a delisting agreement in which Haron Holding S.A. has undertaken to offer the shareholders [ … ]